Form 10-Q CATALYST PHARMACEUTICALS For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Catyalyst Pharma (CPRX) Reports In-Line Q1 Loss
May 10, 2016 4:57 PM EDTCatyalyst Pharma (NASDAQ: CPRX) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07).
Upcoming 2016 Milestones
Collaboratively working with the FDA to finalize a regulatory path forward for FirdapseInitiate the confirmatory Phase 3 trial for... More